» Articles » PMID: 37952118

European Health Data & Evidence Network-learnings from Building out a Standardized International Health Data Network

Abstract

Objective: Health data standardized to a common data model (CDM) simplifies and facilitates research. This study examines the factors that make standardizing observational health data to the Observational Medical Outcomes Partnership (OMOP) CDM successful.

Materials And Methods: Twenty-five data partners (DPs) from 11 countries received funding from the European Health Data Evidence Network (EHDEN) to standardize their data. Three surveys, DataQualityDashboard results, and statistics from the conversion process were analyzed qualitatively and quantitatively. Our measures of success were the total number of days to transform source data into the OMOP CDM and participation in network research.

Results: The health data converted to CDM represented more than 133 million patients. 100%, 88%, and 84% of DPs took Surveys 1, 2, and 3. The median duration of the 6 key extract, transform, and load (ETL) processes ranged from 4 to 115 days. Of the 25 DPs, 21 DPs were considered applicable for analysis of which 52% standardized their data on time, and 48% participated in an international collaborative study.

Discussion: This study shows that the consistent workflow used by EHDEN proves appropriate to support the successful standardization of observational data across Europe. Over the 25 successful transformations, we confirmed that getting the right people for the ETL is critical and vocabulary mapping requires specific expertise and support of tools. Additionally, we learned that teams that proactively prepared for data governance issues were able to avoid considerable delays improving their ability to finish on time.

Conclusion: This study provides guidance for future DPs to standardize to the OMOP CDM and participate in distributed networks. We demonstrate that the Observational Health Data Sciences and Informatics community must continue to evaluate and provide guidance and support for what ultimately develops the backbone of how community members generate evidence.

Citing Articles

The arisal of data spaces: why I am excited and worried.

Peeters L Front Immunol. 2024; 15:1461361.

PMID: 39502694 PMC: 11534855. DOI: 10.3389/fimmu.2024.1461361.


Transforming a Large-Scale Prostate Cancer Outcomes Dataset to the OMOP Common Data Model-Experiences from a Scientific Data Holder's Perspective.

Sibert N, Soff J, La Ferla S, Quaranta M, Kremer A, Kowalski C Cancers (Basel). 2024; 16(11).

PMID: 38893186 PMC: 11171220. DOI: 10.3390/cancers16112069.


Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force.

Fleurence R, Kent S, Adamson B, Tcheng J, Balicer R, Ross J Value Health. 2024; 27(6):692-701.

PMID: 38871437 PMC: 11182651. DOI: 10.1016/j.jval.2024.01.019.


Sharing sensitive data in life sciences: an overview of centralized and federated approaches.

Rujano M, Boiten J, Ohmann C, Canham S, Contrino S, David R Brief Bioinform. 2024; 25(4).

PMID: 38836701 PMC: 11151787. DOI: 10.1093/bib/bbae262.


OHDSI-compliance: a set of document templates facilitating the implementation and operation of a software stack for real-world evidence generation.

Wirth F, Abu Attieh H, Prasser F Front Med (Lausanne). 2024; 11():1378866.

PMID: 38818399 PMC: 11137233. DOI: 10.3389/fmed.2024.1378866.


References
1.
Papez V, Moinat M, Voss E, Bazakou S, Van Winzum A, Peviani A . Transforming and evaluating the UK Biobank to the OMOP Common Data Model for COVID-19 research and beyond. J Am Med Inform Assoc. 2022; 30(1):103-111. PMC: 9619789. DOI: 10.1093/jamia/ocac203. View

2.
Ong T, Pradhananga R, Holve E, Kahn M . A Framework for Classification of Electronic Health Data Extraction-Transformation-Loading Challenges in Data Network Participation. EGEMS (Wash DC). 2018; 5(1):10. PMC: 5994935. DOI: 10.5334/egems.222. View

3.
Reisinger S, Ryan P, OHara D, Powell G, Painter J, Pattishall E . Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc. 2010; 17(6):652-62. PMC: 3000752. DOI: 10.1136/jamia.2009.002477. View

4.
Puttmann D, de Keizer N, Cornet R, Van Der Zwan E, Bakhshi-Raiez F . FAIRifying a Quality Registry Using OMOP CDM: Challenges and Solutions. Stud Health Technol Inform. 2022; 294:367-371. DOI: 10.3233/SHTI220476. View

5.
FitzHenry F, Resnic F, Robbins S, Denton J, Nookala L, Meeker D . Creating a Common Data Model for Comparative Effectiveness with the Observational Medical Outcomes Partnership. Appl Clin Inform. 2015; 6(3):536-47. PMC: 4586341. DOI: 10.4338/ACI-2014-12-CR-0121. View